Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shirin Rizzardo"'
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives To assess the distribution and spending by cost-effectiveness category among those drugs with the highest public spending levels in Canada.Design Repeated cross-sectional study.Setting The Canadian provinces of Manitoba, Ontario, New Bruns
Externí odkaz:
https://doaj.org/article/a084f3e5ebc341abb55d47c427966e1e
Autor:
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Larry Lynd, Eric Lun, Bob Nakagawa, Dean Regier, Shirin Rizzardo, Anne McFarlane
Publikováno v:
HealthcarePapers. 21:10-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c25502315516dafc9fe654698131a3ce
https://doi.org/10.12927/hcpap.2023.27000
https://doi.org/10.12927/hcpap.2023.27000
Autor:
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Eric Lun, Bob Nakagawa, Dean Regier, Shirin Rizzardo, Anne McFarlane
Publikováno v:
HealthcarePapers. 21:74-80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83266794fba7670c23df9914b518ebd1
https://doi.org/10.12927/hcpap.2023.26992
https://doi.org/10.12927/hcpap.2023.26992
Autor:
Litsa Blanis, Craig Mitton, Kathy Li, Carlo A. Marra, Shirin Rizzardo, Nick Bansback, Nick Dragojlovic, Larry D. Lynd, Conor M.W. Douglas
Publikováno v:
Value in Health. 22:362-369
Background Decision makers are facing growing challenges in prioritizing drugs for reimbursement because of soaring drug costs and increasing pressures on financial resources. In addition to cost and effectiveness, payers are using other values to di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69cb064db1751196cb29bc4a3db162bb
https://doi.org/10.1016/j.jval.2018.08.008
https://doi.org/10.1016/j.jval.2018.08.008
Autor:
Shirin Rizzardo, Nick Dragojlovic, Craig Mitton, Nick Bansback, Carlo A. Marra, Larry D. Lynd
Publikováno v:
The patient. 8(1)
Background Expensive drugs for rare diseases (i.e. orphan drugs) often do not meet traditional cost-effectiveness criteria and thus put further strain on limited healthcare budgets. Failing to provide medically necessary care to patients, however, vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828135c041d79a9e0c78ded93d7a75ff
https://pubmed.ncbi.nlm.nih.gov/25586645
https://pubmed.ncbi.nlm.nih.gov/25586645
Publikováno v:
Value in Health. 17(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac4de4e2cf1bc1a918d694f0ce5166b
Publikováno v:
Value in Health. 17:A234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0efce2289db0ae0045b66d4b9655161b
https://doi.org/10.1016/j.jval.2014.03.1364
https://doi.org/10.1016/j.jval.2014.03.1364